Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia.

Literature DB >> 17613775

Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia.

Don M Benson, Megan K Smith.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Thalidomide
Lenalidomide

Year: 2007 PMID： 17613775 DOI： 10.1080/10428190701361851

Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Plasma cell leukemia.

Authors: Moria A Gertz; Francis K Buadi
Journal: Haematologica Date: 2010-05 Impact factor: 9.941

2. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.

Authors: Yasunobu Sekiguchi; Asami Shimada; Mutsumi Wakabayashi; Keiji Sugimoto; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal: Int J Clin Exp Pathol Date: 2014-08-15

Review 3. How I treat plasma cell leukemia.

Authors: Niels W C J van de Donk; Henk M Lokhorst; Kenneth C Anderson; Paul G Richardson
Journal: Blood Date: 2012-07-26 Impact factor: 22.113

Review 4. Plasma cell leukaemia and other aggressive plasma cell malignancies.

Authors: Taimur Sher; Kena C Miller; George Deeb; Kelvin Lee; Asher Chanan-Khan
Journal: Br J Haematol Date: 2010-08 Impact factor: 6.998

Review 5. Plasma cell leukemia.

Authors: Flavio Albarracin; Rafael Fonseca
Journal: Blood Rev Date: 2011-02-03 Impact factor: 8.250

Review 6. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Authors: C Fernández de Larrea; R A Kyle; B G M Durie; H Ludwig; S Usmani; D H Vesole; R Hajek; J F San Miguel; O Sezer; P Sonneveld; S K Kumar; A Mahindra; R Comenzo; A Palumbo; A Mazumber; K C Anderson; P G Richardson; A Z Badros; J Caers; M Cavo; X LeLeu; M A Dimopoulos; C S Chim; R Schots; A Noeul; D Fantl; U-H Mellqvist; O Landgren; A Chanan-Khan; P Moreau; R Fonseca; G Merlini; J J Lahuerta; J Bladé; R Z Orlowski; J J Shah
Journal: Leukemia Date: 2012-11-21 Impact factor: 11.528